Therapy and clinical trials.
dc.contributor.author | Sodhi, Nishtha | |
dc.contributor.author | Krasuski, Richard A | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2015-12-03T17:18:43Z | |
dc.date.issued | 2013-06 | |
dc.identifier | ||
dc.identifier | 00041433-201306000-00018 | |
dc.identifier.eissn | 1473-6535 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
dc.relation.ispartof | Curr Opin Lipidol | |
dc.relation.isversionof | 10.1097/MOL.0b013e3283616351 | |
dc.subject | Antibodies, Monoclonal | |
dc.subject | Anticholesteremic Agents | |
dc.subject | Cholesterol, LDL | |
dc.subject | Clinical Trials as Topic | |
dc.subject | Drug Administration Routes | |
dc.subject | Drug Administration Schedule | |
dc.subject | Humans | |
dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors | |
dc.subject | Hyperlipoproteinemia Type II | |
dc.subject | Niacin | |
dc.subject | Oligonucleotides | |
dc.subject | Proprotein Convertase 9 | |
dc.subject | Proprotein Convertases | |
dc.subject | Serine Endopeptidases | |
dc.title | Therapy and clinical trials. | |
dc.type | Journal article | |
duke.contributor.orcid | Krasuski, Richard A|0000-0003-3150-5215 | |
pubs.author-url | ||
pubs.begin-page | 281 | |
pubs.end-page | 282 | |
pubs.issue | 3 | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Cardiology | |
pubs.organisational-group | School of Medicine | |
pubs.publication-status | Published | |
pubs.volume | 24 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Nishtha Lipid.pdf
- Size:
- 136.33 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version